Clinical Trial Update: Combination Chemotherapy in Treating Patients With Stage II or Stage III Multiple Myeloma [Phase 3]

View source ↗

Summary

This is an update on a Phase 3 trial evaluating combination chemotherapy for stage II/III multiple myeloma that has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Plasma Cell Neoplasm

Snippet

Sponsor: West of Scotland Lymphoma Group | Conditions: Multiple Myeloma and Plasma Cell Neoplasm | Phase 3 | Status: COMPLETED